{"text": ["Lilly", "breast", "cancer", "drug", "wins", "expanded", "U.S.", "approval"], "created_at": "2018-02-26 22:13:58"}
{"text": ["Lilly", "Receives", "Additional", "FDA", "Approval", "for", "VerzenioTM", "(abemaciclib),", "as", "Initial", "Treatment", "for", "Advanced", "Breast", "Cancer"], "created_at": "2018-02-26 21:16:00"}
{"text": ["Eli", "Lilly", "Announces", "Additional", "FDA", "Approval", "For", "Verzenio", "-", "Quick", "Facts"], "created_at": "2018-02-26 16:25:00"}
{"text": ["Eli", "Lilly", "Announces", "Additional", "FDA", "Approval", "For", "Verzenio", "-", "Quick", "Facts"], "created_at": "2018-02-26 16:25:00"}
{"text": ["Radius", "Health", "(RDUS)", "to", "Disappoint", "Investors", "in", "Q4", "Earnings?"], "created_at": "2018-02-26 16:12:20"}
{"text": ["Radius", "Health", "(RDUS)", "to", "Disappoint", "Investors", "in", "Q4", "Earnings?"], "created_at": "2018-02-26 16:12:20"}
{"text": ["Health", "Care", "Sector", "Update", "for", "02/26/2018:", "ACHN,", "OBSV,", "EGRX,", "LLY,", "CNC"], "created_at": "2018-02-26 14:07:09"}
{"text": ["Health", "Care", "Sector", "Update", "for", "02/26/2018:", "ACHN,", "OBSV,", "EGRX,", "LLY,", "CNC"], "created_at": "2018-02-26 14:07:09"}
{"text": ["Johnson", "&", "Johnson\u2019s", "Neuroscience", "Segment", "in", "2017"], "created_at": "2018-02-26 12:31:42"}
{"text": ["New", "Data", "Show", "Lilly's", "Trulicity\u00ae", "(dulaglutide)", "in", "Combination", "with", "an", "SGLT-2", "Inhibitor", "Improves", "Blood", "Sugar", "Control", "in", "People", "with", "Type", "2", "Diabetes"], "created_at": "2018-02-26 11:45:00"}
{"text": ["Eli", "Lilly", "Reports", "New", "Data", "From", "Trulicity", "Phase", "3b", "Study", "-", "Quick", "Facts"], "created_at": "2018-02-26 07:03:00"}
{"text": ["Eli", "Lilly", "Reports", "New", "Data", "From", "Trulicity", "Phase", "3b", "Study", "-", "Quick", "Facts"], "created_at": "2018-02-26 07:03:00"}
